Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids)
Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169)
06/2003
06/12/2003WO2003027282A9 Adamts-15, -16, -17, -18 and -19
06/12/2003WO2002103031A3 Methods for detecting and treating the early onset of aging-related conditions
06/12/2003WO2002064094A3 2-aryloxy-2-arylalkanoic acids for diabetes and lipid disorders
06/12/2003WO2002012345A3 Soluble zcytor 11 cytokine receptors
06/12/2003WO2002009683A9 Aldosterone blocker therapy to prevent or treat inflammation-related disorders
06/12/2003WO2002000192A8 Embolization using carbon coated particles
06/12/2003WO2001085096A9 Mast cell regulation
06/12/2003US20030109813 Energy-activated targeted cancer therapy
06/12/2003US20030109715 3,4-Dihydro-1H-naphthalene derivatives as a highly selective cyclooxygenase-2 inhibitor
06/12/2003US20030109709 Processes for the preparation of 1,5-diaryl-3-substituted-pyrazoles
06/12/2003US20030109701 Crystalline forms of meloxicam and processes for their preparation and interconversion
06/12/2003US20030109671 Therapeutic agents and methods of use thereof for the modulation of angiogenesis
06/12/2003US20030109578 Treating acute and chronical inflammatory processes in a patent in need thereof which comprises administering to such patent an amount effective therefor of a compound or salt thereof according to claim 1.
06/12/2003US20030109570 Activate a peroxisome proliferator-activated receptor (PPAR) alpha or gamma which is an intranuclear transcription factor. The compound may be used as an active ingredient to give a drug for preventing or treating a variety of diseases
06/12/2003US20030109565 Administered by any means other than orally, characterized in that it comprises xylitol, and more particularly to an antipyretic preparation characterized in that it consists of an antipyretic and a synergistic amount of xylitol.
06/12/2003US20030109556 Melanocortin receptor ligands
06/12/2003US20030109550 Substituted indazole compounds for the treatment of inflammation
06/12/2003US20030109538 Pyrmidine derivatives as selective inhibitors of cox-2
06/12/2003US20030109527 Novel hydroxy diphenylurea sulfonamides, compositions and intermediates thereof. The hydroxy
06/12/2003US20030109526 Azo amino acids derivatives
06/12/2003US20030109520 Compositions and methods to prevent toxicity induced by nonsteroidal antiinflammatory drugs
06/12/2003US20030109518 Substituted 1,4-benzodiazepines and uses thereof
06/12/2003US20030109517 Azacycloalkanone serine protease inhibitors
06/12/2003US20030109511 Novel anti-inflammatory androstane derivative compositions
06/12/2003US20030109497 Novel imidazolidine derivatives, their preparation and their use
06/12/2003US20030109491 Use of heparinoid derivatives for the treatment and diagnosis of disorders which can be treated with heparinoids
06/12/2003US20030109474 Gene, encoding a subunit of the transcription factor AP-1, of its genome is inactivated and/or a component, acting on the AP-1 transcription factor, of the signal transduction pathway is modified resulting in a modified AP-1 activity and
06/12/2003US20030109437 Peptides and methods of treating conditions requiring removal or destruction of harmful or unwanted cells in a patient, such as benign and malignant tumors, using proteins (and peptides derived from the amino acid sequences of such
06/12/2003US20030109429 Methods for the production of purified recombinant human uteroglobin for the treatment of inflammatory and fibrotic conditions
06/12/2003US20030108998 Aggrecan degrading metallo proteases
06/12/2003US20030108928 MID 241 receptor, a novel G-protein coupled receptor
06/12/2003US20030108617 Use of a formulation made of or containing at least one dissimilated milk serum
06/12/2003US20030108603 Mixture of protein, hydrophilic polymer, group 1a alkyl sulfate and sugar
06/12/2003US20030108597 Application of lipid vehicles and use for drug delivery
06/12/2003US20030108588 Reduce restenosis coating on medical device
06/12/2003US20030108575 Stabilized oral suspension formulation
06/12/2003US20030108540 Inducing apoptosis in tissues; binding antibodies
06/12/2003US20030108510 Synergistic mixture of rutin, escin and bufemin; branching of arteries, veins
06/12/2003US20030108496 Compositions comprising phenyl-glycine derivatives
06/12/2003US20030108493 Extracts from residues left in the production of wine
06/12/2003US20030107149 Thin film with non-self-aggregating uniform heterogeneity and drug delivery systems made therefrom
06/12/2003CA2819733A1 Use of selenite-containing compounds to be topically or buccally administered for treating or preventing sunburn
06/12/2003CA2819731A1 Use of selenite-containing compounds to be topically or buccally administered for treating an insect bite
06/12/2003CA2735287A1 Use of selenite-containing compounds to be topically or buccally administered
06/12/2003CA2469395A1 Novel inhibitor compounds specific of secreted non-pancreatic human a2 phospholiphase of group ii
06/12/2003CA2469227A1 New compounds and their use in medicine, process for their preparation and pharmaceutical compositions containing them
06/12/2003CA2469085A1 Pharmaceutical combinations of adenosine a-2a and beta-2-adrenergic receptor agonists
06/12/2003CA2469078A1 Immunotherapeutic methods and systems
06/12/2003CA2468927A1 Ring fused pyrazole derivatives
06/12/2003CA2468907A1 Effectors of innate immunity
06/12/2003CA2468698A1 Methods and compositions for modulating the immune system and uses thereof
06/12/2003CA2468676A1 Combination of a selective pde4 inhibitor and an adrenergic beta-2 receptor agonist
06/12/2003CA2468525A1 Process for the preparation of compositions having an increased amount of pharmaceutically active salts of rotamers of 4-[4-[(1r)-[4-(trifluoromethyl)phenyl]-2-methoxyethyl]-(3s)-methyl-1-piperazinyl]-4-methyl-1-[(4,6-dimethyl-5-pyrimidinyl)carbonyl]
06/12/2003CA2468407A1 Compositions and methods for detecting and treating diseases and conditions related to chemokine receptors
06/12/2003CA2468349A1 Pyrimidine compounds
06/12/2003CA2468067A1 Metabotropic glutamate receptor-5 modulators
06/12/2003CA2467435A1 Substituted 2-amino-cycloalkanecarboxamides and their use as cysteine protease inhibitors
06/11/2003EP1318407A1 Use of aldose-1-epimerase (mutarotase) for the diagnosis and therapy of infections and sepsis
06/11/2003EP1318150A1 Novel crystals of 1,3,4-oxadiazole derivative, process for producing the crystals and medicines containing the same as the active ingredient
06/11/2003EP1318149A1 Amidine derivatives, their preparation and application as medicines and pharmaceutical compositions containing them
06/11/2003EP1317926A1 Xenon inhalant for pain treatment
06/11/2003EP1317924A1 Kit for reducing aching caused by pde-v inhibitors
06/11/2003EP1317922A1 Antipyretic preparation containing xylitol
06/11/2003EP1317536A2 Tnf receptor-like molecules and uses thereof
06/11/2003EP1317488A2 Site-specific, antibody-mediated activation of proapoptotic cytokine: amaice (antibody-mediated apoptosis inducing cytokine)
06/11/2003EP1317487A2 Caveolin peptides and their use as therapeutics
06/11/2003EP1317483A2 Variants of allergenic proteins of the group 2 of dermatophagoides
06/11/2003EP1317465A1 Purine derivatives
06/11/2003EP1317458A2 Interphenylene 7-oxabicyclic[2.2.1]heptane oxazoles as prostaglandin f2alpha antagonists
06/11/2003EP1317457A2 INTERHETEROARYL 7-OXABICYCLIC 2.2.1]HEPTANE OXAZOLES AS PROSTAGLANDIN F 2$g(a)? ANTAGONISTS
06/11/2003EP1317454A2 Caspase inhibitors and uses thereof
06/11/2003EP1317453A1 Isoxazoles and their use as inhibitors of erk
06/11/2003EP1317452A1 Pyrazole compounds useful as protein kinase inhibitors
06/11/2003EP1317450A1 Pyrazole compounds useful as protein kinase inhibitors
06/11/2003EP1317449A1 Pyrazole compounds useful as protein kinase inhibitors
06/11/2003EP1317448A1 Pyrazole compounds useful as protein kinase inhibitors
06/11/2003EP1317447A1 Pyrazole compounds useful as protein kinase inhibitors
06/11/2003EP1317446A1 Oxindole derivatives
06/11/2003EP1317444A1 Pyrazole compounds useful as protein kinase inhibitors
06/11/2003EP1317443A2 Chemokine receptor binding heterocyclic compounds
06/11/2003EP1317421A1 2-amino-2-alkyl-5 heptenoic and heptynoic acid derivatives useful as nitric oxide synthase inhibitors
06/11/2003EP1317420A1 2-amino-2-alkyl-3 hexenoic and hexynoic acid derivatives useful as nitric oxide synthase inhibitors
06/11/2003EP1317417A2 2-amino-2-alkyl-3 heptenoic and heptynoic acid derivatives useful as nitric oxide synthase inhibitors
06/11/2003EP1317416A2 2-amino-2-alkyl-4 hexenoic and hexynoic acid derivatives useful as nitric oxide synthase inhibitors
06/11/2003EP1317283A2 Tweak receptor agonists as anti-angiogenic agents
06/11/2003EP1317282A2 VECTORS FOR MOLECULE DELIVERY TO CD11b EXPRESSING CELLS
06/11/2003EP1317272A2 Composition for improving the cell protection comprising a lipophilic antioxidant an a hydrophilic antioxidant
06/11/2003EP1317267A2 Compositions containing diacyltartaric salts of (e)-metanicotine
06/11/2003EP1060161B1 Matrix metalloproteinase inhibitors
06/11/2003EP1021413B1 The preparation and use of ortho-sulfonamido bicyclic heteroaryl hydroxamic acids as matrix metalloproteinase and tace inhibitors
06/11/2003EP0750511B1 Treating inflammation via the administration of specific sulfatase enzymes and/or sulfation inhibitor
06/11/2003CN1423700A Multifunctional polypeptides comprising a binding site to and epitope of the NKG2D receptor complex
06/11/2003CN1423658A Modulation of human sodium channels in dorsal root ganglia
06/11/2003CN1423651A New use and novel N-azabicyclo-amide derivatives
06/11/2003CN1423649A Sulfonyl oxazole amines and their use as 5-HT6 receptor ligand
06/11/2003CN1423647A Beta-alanine derivatives and their use as receptor antagonists
06/11/2003CN1423646A Hetero cyclo-alkylsulfonyl pyrazole derivatives as anti-inflammatory/analgesic agents
06/11/2003CN1423645A 维他命d类似物 Vitamin d analogues
06/11/2003CN1423627A 维生素d类似物 Vitamin d analogues
06/11/2003CN1423528A Nutritional modules
1 ... 836 837 838 839 840 841 842 843 844 845 846 847 848 849 850 851 852 853 854 855 856 ... 1272